Priority Launch Portfolio
Essential platinum-based and topoisomerase inhibitor chemotherapy agents for hospital oncology settings. WHO-GMP certified sterile injectables for first-line cancer treatment.
Explore our portfolio of 4 high-quality oncology products designed to meet the highest international standards.
First-generation platinum agent for multiple solid tumors. FDA-approved chemotherapy standard for ovarian, testicular, and bladder cancers.
Indications:
Second-generation platinum agent with improved tolerability. Widely used in combination regimens for various solid tumors.
Indications:
Third-generation platinum compound. Essential component of FOLFOX regimen for colorectal cancer treatment.
Indications:
Topoisomerase II inhibitor. Critical agent for lung cancer and germ cell tumors in combination chemotherapy.
Indications:
Our commitment to quality is backed by international certifications and regulatory compliance across multiple markets.
Available
Products manufactured at WHO Good Manufacturing Practice certified facilities
36AARCP2455C1Z8
Registered for Goods and Services Tax in India
UDYAM-TS-02-0354028
Micro, Small and Medium Enterprises registration
Just say available
Central and state drug regulatory approvals in India
International regulatory submissions for major markets
Interested in our oncology products? Contact us for product catalogs, regulatory documentation, or partnership opportunities.
Oncology product development and registration
Technology transfer and formulation development
Contract manufacturing partnerships with WHO-GMP facilities
Regulatory dossier support for FDA, EMA, TGA, COFEPRIS and Asian markets
Licensing and distribution partnerships globally
Contact our team for detailed product specifications, regulatory documentation, or partnership opportunities.